Private-label products sit at the center of a liability question that surprises many business owners the first time it comes up in litigation: when a private-label product injures a consumer, who actually bears responsibility, the brand whose name is on the label, or the contract manufacturer that actually made the product? The answer, as most product liability attorneys will confirm, is usually both, but the specific allocation of responsibility depends heavily on contract language, supply chain documentation, and how the failure occurred.
The Basic Legal Framework
Product liability law generally allows an injured consumer to pursue claims against any party in the chain of distribution, including the retailer whose brand appears on the label, the contract manufacturer who physically produced the item, and any component suppliers whose materials contributed to the defect. This means a private-label brand cannot simply point to its manufacturing agreement and walk away from a claim. Courts have consistently held that the entity marketing a product under its own name assumes a duty to consumers independent of who actually manufactured it.
At the same time, contract manufacturers are not shielded from liability simply because their name never appears on the packaging. Manufacturing defect claims, in particular, tend to focus directly on production processes, quality control, and facility practices, all of which sit squarely within the contract manufacturer’s control rather than the brand’s.
Where Contracts Matter Most
The manufacturing agreement between a private-label brand and its contract manufacturer is often the single most important document once litigation begins. Indemnification clauses, insurance requirements, and specification sign-off procedures all shape how liability gets allocated between the parties, even though none of that internal allocation affects the injured consumer’s ability to sue either party directly. Industry analysis from Amerisure emphasizes that brands frequently discover gaps in their indemnification language only after a claim has already been filed, at which point renegotiating the contract does nothing to help the current dispute.
Strong manufacturing agreements typically define specification approval in detail, since a defect resulting from the brand’s own formulation instructions shifts responsibility differently than a defect resulting from the manufacturer deviating from those instructions during production. This distinction, formulation versus execution, often becomes the central factual question in contract manufacturing liability disputes.
Insurance Requirements Across the Supply Chain
Because liability in private-label arrangements is rarely clean or one-sided, insurance coverage on both sides of the relationship matters enormously. Brands typically require contract manufacturers to carry their own product liability coverage and to name the brand as an additional insured on that policy. This arrangement, when properly documented, allows the brand’s own insurer to pursue the manufacturer’s carrier for reimbursement after a claim is paid, rather than leaving the brand to absorb the full cost independently.
Coverage guidance from Liberty Mutual notes that manufacturers should carry coverage limits that reflect not just their own direct sales, but the scale of the private-label brands they produce for, since a single contamination event across a shared production line can generate claims volume far beyond what a manufacturer’s own retail footprint would suggest. Specialized coverage analysis from The Coyle Group similarly highlights that additional insured endorsements and waiver of subrogation clauses are frequently negotiated incorrectly or left out entirely, creating coverage gaps that only surface once a claim tests the actual policy language.
Common Points of Failure in Private-Label Arrangements
Several recurring issues tend to surface once a private-label product liability claim moves into discovery:
- Ambiguous specification approval records that make it unclear whether a defect originated in the brand’s formulation or the manufacturer’s execution.
- Additional insured endorsements that were promised in the manufacturing agreement but never actually issued by the manufacturer’s insurer.
- Inadequate batch testing or record retention on the manufacturer’s side, leaving no documentation to establish quality control at the time of production.
- Shared production lines across multiple brands, which can complicate root cause analysis when a contamination or defect issue is not isolated to a single product.
Brands that audit these areas proactively, rather than waiting until a claim forces the issue, consistently fare better both in litigation outcomes and in insurance renewal negotiations.
Practical Steps for Brands Working With Contract Manufacturers
Businesses relying on contract manufacturing for private-label products can reduce their liability exposure meaningfully through a few consistent practices. Requiring documented proof of insurance, not just a promise of coverage, before production begins is a baseline safeguard. Conducting periodic facility audits, even for long-standing manufacturing relationships, helps catch quality control drift before it results in a defective batch. Maintaining detailed records of every specification change and sign-off protects the brand’s position on the formulation versus execution question if a dispute arises later.
Brands should also revisit indemnification and insurance requirements whenever production volume or product complexity changes significantly, since agreements negotiated for a small initial order often do not scale appropriately as a product line grows.
Why This Matters Beyond Litigation
Clear liability allocation in contract manufacturing relationships is not only a legal safeguard, it directly affects how quickly and effectively a defect gets identified and corrected. When responsibility is ambiguous, root cause investigations slow down, recalls take longer to execute, and consumers remain exposed to risk longer than necessary. Brands and manufacturers that build clear liability frameworks into their relationship from the start tend to respond faster and more effectively when something does go wrong, which matters both for consumer safety and for limiting the scope of eventual claims.
Conclusion
Private-label product failures rarely have a single responsible party. Instead, liability is distributed across brand and manufacturer according to contract terms, specification control, and the specific nature of the defect. Businesses on either side of a contract manufacturing relationship that invest in clear agreements, proper insurance documentation, and consistent quality control records put themselves in a far stronger position when, not if, a claim eventually arises.
